Picture of Qly Biotech logo

LQLY Qly Biotech Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro Cap

Annual cashflow statement for Qly Biotech, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

2019
August 31st
2020
August 31st
2021
August 31st
2022
August 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-0.001-0.005-0.029-0.014
Depreciation
Amortisation
Changes in Working Capital0.002-0.002
Change in Accounts Payable
Cash from Operating Activities-0.001-0.004-0.026-0.014
Capital Expenditures-0.0050
Purchase of Fixed Assets
Cash from Investing Activities-0.0050
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.0060.0320.0040.009
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0050.023-0.022-0.005